Dr Lal Pathlabs Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹702.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.50 per cent from ₹659.80 crore. This corresponds to a year-on-year *(YoY) growth of 16.61 per cent.
Operating Profit
Operating Profit stands at ₹186.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.20 per cent from ₹149.20 crore. This corresponds to a year-on-year *(YoY) growth of 10.53 per cent.
PBDT
PBDT stands at ₹204.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 23.02 per cent from ₹166.40 crore. This corresponds to a year-on-year *(YoY) growth of 7.85 per cent.
Profit Before Tax
Profit Before Tax stands at ₹160.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.80 per cent from ₹124.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.37 per cent.
Net Profit
Net Profit stands at ₹132.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.64 per cent from ₹91.40 crore. This represents a 14.98 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Lal Pathlabs Ltd News
Dr Lal Pathlabs Ltd Earnings
- YOY
- QOQ
Dr Lal Pathlabs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Lal Pathlabs Ltd Research Reports
Dr Lal Pathlabs Ltd Financial Reports
Dr Lal Pathlabs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Lal Pathlabs | -0.55% | -2.33% | -1.61% | 13.01% | 4.00% | 7.32% |
| Aster DM Health. | 1.32% | 4.00% | 1.60% | 13.98% | 21.25% | 31.75% |
| Global Health | 0.95% | 6.00% | 1.99% | 13.70% | 6.86% | 3.34% |
| Krishna Institu. | 2.98% | 4.69% | 11.50% | 13.72% | 16.45% | 20.42% |
| Syngene Intl. | -0.23% | -3.04% | -7.44% | 8.94% | -31.23% | -33.85% |
| Dr Agarwal's Hea | -0.75% | -4.80% | 1.38% | 1.94% | -8.49% | 22.37% |
| Poly Medicure | 1.04% | 6.40% | -15.39% | 7.80% | -23.55% | -37.51% |
Company Info
Company Information
Chairman cum Managing Director : Arvind Lal
Whole-time Director : Vandana Lal
Whole Time Director & CEO : Om Prakash Manchanda
Director : Rahul Sharma
Independent Director : Arun Duggal
Independent Director : Anoop Mahendra Singh
Independent Director : Sunil Varma
Independent Director : Harneet Singh Chandhoke
Independent Director : Saurabh Srivastava
Company Secretary : Rajat Kalra